{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:25:24Z","timestamp":1789770324019,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T00:00:00Z","timestamp":1564790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T00:00:00Z","timestamp":1564790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s11060-019-03257-1","type":"journal-article","created":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T07:02:36Z","timestamp":1564815756000},"page":"553-562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation"],"prefix":"10.1007","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7423-8172","authenticated-orcid":false,"given":"Denise D.","family":"Correa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kryza-Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Wai","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Panageas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Abrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"DeAngelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Omuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,3]]},"reference":[{"key":"3257_CR1","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1200\/JCO.2013.50.4910","volume":"31","author":"PG Morris","year":"2013","unstructured":"Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, Grimm S, Lai RK, Reiner AS, Panageas K, Karimi S, Curry R, Shah G, Abrey LE, DeAngelis LM, Omuro A (2013) Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol 31:3971\u20133979. \n                    https:\/\/doi.org\/10.1200\/JCO.2013.50.4910","journal-title":"J Clin Oncol"},{"key":"3257_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S1470-2045(10)70229-1","volume":"11","author":"E Thiel","year":"2010","unstructured":"Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M, Roth A, Hertenstein B, von Toll T, Hundsberger T, Mergenthaler HG, Leithauser M, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Plasswilm L, Nagele T, Pietsch T, Bamberg M, Weller M (2010) High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol 11:1036\u20131047. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(10)70229-1","journal-title":"Lancet Oncol"},{"key":"3257_CR3","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1200\/JCO.2002.11.013","volume":"20","author":"LM DeAngelis","year":"2002","unstructured":"DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ, Radiation Therapy Oncology Group S (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93\u201310. J Clin Oncol 20:4643\u20134648","journal-title":"J Clin Oncol"},{"key":"3257_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-1-59259-317-0_14","volume-title":"Cancer neurology in clinical practice","author":"A Behin","year":"2003","unstructured":"Behin A, DeLattre JY (2003) Neurologic sequelae of radiotherapy on the nervous system. In: Schiff D, Wen PY (eds) Cancer neurology in clinical practice. Humana Press, Totowa, pp 173\u2013191"},{"key":"3257_CR5","first-page":"551","volume-title":"Neurologic complications of cancer","author":"LM DeAngelis","year":"2009","unstructured":"DeAngelis LM, Posner JB (2009) Side effects of radiation therapy. In: DeAngelis LM, Posner JB (eds) Neurologic complications of cancer, 2nd edn. Oxford University Press, New York, pp 551\u2013555","edition":"2"},{"key":"3257_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pbc.24263","volume":"60","author":"M Monje","year":"2013","unstructured":"Monje M, Thomason ME, Rigolo L, Wang Y, Waber DP, Sallan SE, Golby AJ (2013) Functional and structural differences in the hippocampus associated with memory deficits in adult survivors of acute lymphoblastic leukemia. Pediatr Blood Cancer 60:293\u2013300. \n                    https:\/\/doi.org\/10.1002\/pbc.24263","journal-title":"Pediatr Blood Cancer"},{"key":"3257_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/jbiol50","volume":"5","author":"J Dietrich","year":"2006","unstructured":"Dietrich J, Han R, Yang Y, Mayer-Proschel M, Noble M (2006) CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 5:1\u201323. \n                    https:\/\/doi.org\/10.1186\/jbiol50","journal-title":"J Biol"},{"key":"3257_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/ana.21214","volume":"62","author":"ML Monje","year":"2007","unstructured":"Monje ML, Vogel H, Masek M, Ligon KL, Fisher PG, Palmer TD (2007) Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies. Ann Neurol 62:515\u2013520. \n                    https:\/\/doi.org\/10.1002\/ana.21214","journal-title":"Ann Neurol"},{"issue":"43\u201355","key":"3257_CR9","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.cell.2018.10.049","volume":"176","author":"EM Gibson","year":"2019","unstructured":"Gibson EM, Nagaraja S, Ocampo A, Tam LT, Wood LS, Pallegar PN, Greene JJ, Geraghty AC, Goldstein AK, Ni L, Woo PJ, Barres BA, Liddelow S, Vogel H, Monje M (2019) Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment. Cell 176(43\u201355):e13. \n                    https:\/\/doi.org\/10.1016\/j.cell.2018.10.049","journal-title":"Cell"},{"key":"3257_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1212\/01.wnl.0000300671.37279.0e","volume":"70","author":"ER Gerstner","year":"2008","unstructured":"Gerstner ER, Carson KA, Grossman SA, Batchelor TT (2008) Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation. Neurology 70:401\u2013402. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000300671.37279.0e","journal-title":"Neurology"},{"key":"3257_CR11","first-page":"258","volume":"26","author":"EA Neuwelt","year":"2005","unstructured":"Neuwelt EA, Guastadisegni PE, Varallyay P, Doolittle ND (2005) Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery. AJNR Am J Neuroradiol 26:258\u2013265","journal-title":"AJNR Am J Neuroradiol"},{"key":"3257_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/annonc\/mdn628","volume":"20","author":"G Illerhaus","year":"2009","unstructured":"Illerhaus G, Marks R, Muller F, Ihorst G, Feuerhake F, Deckert M, Ostertag C, Finke J (2009) High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study. Ann Oncol 20:319\u2013325. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdn628","journal-title":"Ann Oncol"},{"key":"3257_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ana.21824","volume":"67","author":"A Juergens","year":"2010","unstructured":"Juergens A, Pels H, Rogowski S, Fliessbach K, Glasmacher A, Engert A, Reiser M, Diehl V, Vogt-Schaden M, Egerer G, Schackert G, Reichmann H, Kroschinsky F, Bode U, Herrlinger U, Linnebank M, Deckert M, Fimmers R, Schmidt-Wolf IG, Schlegel U (2010) Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Ann Neurol 67:182\u2013189. \n                    https:\/\/doi.org\/10.1002\/ana.21824","journal-title":"Ann Neurol"},{"key":"3257_CR14","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1182\/blood-2014-10-604561","volume":"125","author":"A Omuro","year":"2015","unstructured":"Omuro A, Correa DD, DeAngelis LM, Moskowitz CH, Matasar MJ, Kaley TJ, Gavrilovic IT, Nolan C, Pentsova E, Grommes CC, Panageas KS, Baser RE, Faivre G, Abrey LE, Sauter CS (2015) R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma. Blood 125:1403\u20131410. \n                    https:\/\/doi.org\/10.1182\/blood-2014-10-604561","journal-title":"Blood"},{"key":"3257_CR15","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1016\/S2352-3026(17)30174-6","volume":"4","author":"AJM Ferreri","year":"2017","unstructured":"Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosee P, Binder M, Fabbri A, Torri V, Minacapelli E, Falautano M, Ilariucci F, Ambrosetti A, Roth A, Hemmaway C, Johnson P, Linton KM, Pukrop T, Sonderskov Gorlov J, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Levis A, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Pfreundschuh M, Cabras G, Angrilli F, Ponzoni M, Deckert M, Politi LS, Finke J, Reni M, Cavalli F, Zucca E, Illerhaus G, International Extranodal Lymphoma Study G (2017) Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. Lancet Haematol 4:e510\u2013e523. \n                    https:\/\/doi.org\/10.1016\/S2352-3026(17)30174-6","journal-title":"Lancet Haematol"},{"issue":"10","key":"3257_CR16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1200\/JCO.18.00306","volume":"37","author":"C Houillier","year":"2019","unstructured":"Houillier C, Taillandier L, Dureau S, Lamy T, Laadhari M, Chinot O, Molucon-Chabrot C, Soubeyran P, Gressin R, Choquet S, Damaj G, Thyss A, Abraham J, Delwail V, Gyan E, Sanhes L, Cornillon J, Garidi R, Delmer A, Tanguy ML, Al Jijakli A, Morel P, Bourquard P, Moles MP, Chauchet A, Gastinne T, Constans JM, Langer A, Martin A, Moisson P, Lacomblez L, Martin-Duverneuil N, Delgadillo D, Turbiez I, Feuvret L, Cassoux N, Touitou V, Ricard D, Hoang-Xuan K, Soussain C, Intergroupe G-A, Lymphoma LOCNfC (2019) Radiotherapy or autologous stem-cell transplantation for primary CNS lymphoma in patients 60 years of age and younger: results of the intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study. J Clin Oncol 37(10):823\u2013833. \n                    https:\/\/doi.org\/10.1200\/JCO.18.00306","journal-title":"J Clin Oncol"},{"key":"3257_CR17","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/annonc\/mdl464","volume":"18","author":"DD Correa","year":"2007","unstructured":"Correa DD, Maron L, Harder H, Klein M, Armstrong CL, Calabrese P, Bromberg JE, Abrey LE, Batchelor TT, Schiff D (2007) Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines. Ann Oncol 18:1145\u20131151. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdl464","journal-title":"Ann Oncol"},{"key":"3257_CR18","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1016\/S1470-2045(18)30356-5","volume":"19","author":"M van der Meulen","year":"2018","unstructured":"van der Meulen M, Dirven L, Habets EJJ, van den Bent MJ, Taphoorn MJB, Bromberg JEC (2018) Cognitive functioning and health-related quality of life in patients with newly diagnosed primary CNS lymphoma: a systematic review. Lancet Oncol 19:e407\u2013e418. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(18)30356-5","journal-title":"Lancet Oncol"},{"key":"3257_CR19","volume-title":"The Halstead-Rietan neuropsychological test battery","author":"RWD Reitan","year":"1985","unstructured":"Reitan RWD (1985) The Halstead-Rietan neuropsychological test battery. Neuropsycohological Press, Tucson"},{"key":"3257_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/13854049608406666","volume":"10","author":"D Schretlen","year":"1996","unstructured":"Schretlen D, Bobholz JH, Brandt J (1996) Development and psychometric properties of the brief test of attention. Clin Neuropsychol 10:80\u201389","journal-title":"Clin Neuropsychol"},{"key":"3257_CR21","volume-title":"Controlled oral word association test. Multilingual aphasia examination","author":"L Benton","year":"1994","unstructured":"Benton L, Hamsher K, Sivan A (1994) Controlled oral word association test. Multilingual aphasia examination. AJA Associates, Iowa City"},{"key":"3257_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1076\/clin.12.1.43.1726","volume":"12","author":"RHB Bennedict","year":"1998","unstructured":"Bennedict RHB, Schretlen D, Groninger L, Brandt J (1998) Hopkins verbal learning test-revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol 12:43\u201355","journal-title":"Clin Neuropsychol"},{"key":"3257_CR23","volume-title":"Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and caucasian adults","author":"RK Heaton","year":"2004","unstructured":"Heaton RK, Miller SW, Taylor MJ, Grant I (2004) Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and caucasian adults. Psychological Assessment Resources Inc., Luzt"},{"key":"3257_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561\u2013571","journal-title":"Arch Gen Psychiatry"},{"key":"3257_CR25","volume-title":"Functional assessment of chronic illness therapy (FACIT) measurement system. Research and education core","author":"D Cella","year":"1997","unstructured":"Cella D (1997) Functional assessment of chronic illness therapy (FACIT) measurement system. Research and education core. Evanston Northwestern Healthcare, Evanston"},{"key":"3257_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 149:351\u2013356. \n                    https:\/\/doi.org\/10.2214\/ajr.149.2.351","journal-title":"AJR Am J Roentgenol"},{"key":"3257_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000117270","volume":"36","author":"F Pasquier","year":"1996","unstructured":"Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P (1996) Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 36:268\u2013272. \n                    https:\/\/doi.org\/10.1159\/000117270","journal-title":"Eur Neurol"},{"key":"3257_CR28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s002130051057","volume":"145","author":"AH Young","year":"1999","unstructured":"Young AH, Sahakian BJ, Robbins TW, Cowen PJ (1999) The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology 145:260\u2013266","journal-title":"Psychopharmacology"},{"issue":"Suppl 1","key":"3257_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.1528-1157.2001.00516.x","volume":"42","author":"AP Aldenkamp","year":"2001","unstructured":"Aldenkamp AP (2001) Effects of antiepileptic drugs on cognition. Epilepsia 42(Suppl 1):46\u201349","journal-title":"Epilepsia"},{"key":"3257_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ijrobp.2012.11.031","volume":"85","author":"V Gondi","year":"2013","unstructured":"Gondi V, Hermann BP, Mehta MP, Tome WA (2013) Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol Biol Phys 85:348\u2013354. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2012.11.031","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3257_CR31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1212\/WNL.0b013e318283bb0a","volume":"80","author":"AM Peiffer","year":"2013","unstructured":"Peiffer AM, Leyrer CM, Greene-Schloesser DM, Shing E, Kearns WT, Hinson WH, Tatter SB, Ip EH, Rapp SR, Robbins ME, Shaw EG, Chan MD (2013) Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology 80:747\u2013753. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318283bb0a","journal-title":"Neurology"},{"key":"3257_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/neuonc\/nor186","volume":"14","author":"DD Correa","year":"2012","unstructured":"Correa DD, Shi W, Abrey LE, Deangelis LM, Omuro AM, Deutsch MB, Thaler HT (2012) Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro Oncol 14:101\u2013108. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nor186","journal-title":"Neuro Oncol"},{"key":"3257_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1212\/WNL.0b013e318297eeba","volume":"81","author":"ND Doolittle","year":"2013","unstructured":"Doolittle ND, Korfel A, Lubow MA, Schorb E, Schlegel U, Rogowski S, Fu R, Dosa E, Illerhaus G, Kraemer DF, Muldoon LL, Calabrese P, Hedrick N, Tyson RM, Jahnke K, Maron LM, Butler RW, Neuwelt EA (2013) Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma. Neurology 81:84\u201392. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318297eeba","journal-title":"Neurology"},{"key":"3257_CR34","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1001\/archneur.62.10.1595","volume":"62","author":"AM Omuro","year":"2005","unstructured":"Omuro AM, Ben-Porat LS, Panageas KS, Kim AK, Correa DD, Yahalom J, Deangelis LM, Abrey LE (2005) Delayed neurotoxicity in primary central nervous system lymphoma. Arch Neurol 62:1595\u20131600. \n                    https:\/\/doi.org\/10.1001\/archneur.62.10.1595","journal-title":"Arch Neurol"},{"key":"3257_CR35","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1212\/WNL.62.4.544","volume":"62","author":"H Harder","year":"2004","unstructured":"Harder H, Holtel H, Bromberg JE, Poortmans P, Haaxma-Reiche H, Kluin-Nelemans HC, Menten J, van den Bent MJ (2004) Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology 62:544\u2013547","journal-title":"Neurology"},{"key":"3257_CR36","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/archneur.60.4.563","volume":"60","author":"K Fliessbach","year":"2003","unstructured":"Fliessbach K, Urbach H, Helmstaedter C, Pels H, Glasmacher A, Kraus JA, Klockgether T, Schmidt-Wolf I, Schlegel U (2003) Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma. Arch Neurol 60:563\u2013568. \n                    https:\/\/doi.org\/10.1001\/archneur.60.4.563","journal-title":"Arch Neurol"},{"key":"3257_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s11682-015-9423-3","volume":"10","author":"DD Correa","year":"2016","unstructured":"Correa DD, Wang Y, West JD, Peck KK, Root JC, Baser RE, Thaler HT, Shore TB, Jakubowski A, Saykin AJ, Relkin N (2016) Prospective assessment of white matter integrity in adult stem cell transplant recipients. Brain Imaging Behav 10:486\u2013496. \n                    https:\/\/doi.org\/10.1007\/s11682-015-9423-3","journal-title":"Brain Imaging Behav"},{"key":"3257_CR38","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s11682-013-9221-8","volume":"7","author":"DD Correa","year":"2013","unstructured":"Correa DD, Root JC, Baser R, Moore D, Peck KK, Lis E, Shore TB, Thaler HT, Jakubowski A, Relkin N (2013) A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients. Brain Imaging Behav 7:478\u2013490. \n                    https:\/\/doi.org\/10.1007\/s11682-013-9221-8","journal-title":"Brain Imaging Behav"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03257-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-019-03257-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03257-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T23:09:17Z","timestamp":1596323357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-019-03257-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["3257"],"URL":"https:\/\/doi.org\/10.1007\/s11060-019-03257-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,3]]},"assertion":[{"value":"20 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Correa serves on the Editorial Board of <i>Neuro-Oncology Practice.<\/i> Ms. Reiner serves on the Editorial Board of <i>Journal of the National Cancer Institute<\/i>, <i>Journal of the National Cancer Institute Cancer Spectrum<\/i>. Dr. Panageas serves on the Editorial Board of <i>Clinical Cancer Research<\/i>, <i>Journal National of the Cancer Institute<\/i>, <i>Journal of the National Cancer Institute Cancer Spectrum<\/i>. She holds stock ownership in Johnson and Johnson, Pfizer, Viking Therapeutics, Catalyst Biotech. Dr. DeAngelis serves on the Editorial Board of <i>Neurology, Journal of Neuro-Oncology, The Open Clinical Cancer Journal, CNS Oncology, Neuro-Oncology, and Neuro-Oncology Practice, and Scientific,<\/i> and on the Advisory Board of <i>Sapience Therapeutics.<\/i> Dr. Omuro serves on the Editorial Board of <i>Journal of Neuro-Oncology<\/i> and <i>Neuro-Oncology Practice,<\/i> and has consulted for BTG. Dr. Sauter has served as a paid consultant on Advisory Boards for: Juno Therapeutics, Sanofi-Genzyme, Spectrum Pharmaceuticals, Novartis, Genmab, Precision Biosciences, Kite, a Gilead Company and GSK. He has received research funds for investigator-initiated trials from Juno Therapeutics and Sanofi-Genzyme. Dr. Abrey is a full-time employee and shareholder in Novartis. The following co-authors have no conflicts of interest: Ms. Braun, Ms. Kryza-Lacombe, Dr. Yahalom, and Dr. Ka-Wai Ho.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}